Clinical impact of del Nido cardioplegia in adult cardiac surgery: A prospective randomized trial.


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
11 2023
Historique:
received: 18 05 2021
revised: 09 01 2022
accepted: 23 01 2022
medline: 1 11 2023
pubmed: 14 3 2022
entrez: 13 3 2022
Statut: ppublish

Résumé

The study objective was to assess the benefits of del Nido cardioplegia compared with cold blood cardioplegia solution in terms of myocardial protection during adult cardiac surgery. A total of 474 adult patients undergoing coronary artery bypass grafting, heart valve surgery, thoracic aortic surgery, or combined procedures were randomized to the del Nido cardioplegia group (n = 234) or the cold blood cardioplegia solution group (n = 240) after provided informed consent. The primary end points assessed inotropic support requirements, severe cardiovascular events, and troponin trend within the first 48 hours of intensive care unit stay. Reperfusion arrhythmias, aortic crossclamp and cardiopulmonary bypass times, and other clinical perioperative variables were considered as secondary end points. No statistically significant differences were found regarding postoperative inotropic support requirements or the incidence of severe cardiovascular events. The del Nido cardioplegia group showed a higher return to spontaneous sinus rhythm (P< .001), a lower number of defibrillation attempts (P< .001), and an earlier peak troponin value in the postoperative period. Peak blood glucose levels and intravenous insulin requirements were significantly lower in the del Nido cardioplegia group. We found no significant differences regarding aortic crossclamp or cardiopulmonary bypass time. We did observe a lower incidence of postoperative stroke in the del Nido cardioplegia group (2.6% vs 6.7%; P= .035). del Nido cardioplegia can be used safely and with comparable outcomes compared with traditional cardioplegia solutions. Additional advantages over glycemic control, reperfusion arrhythmias, and its comfortable redosing interval make del Nido an interesting alternative for myocardial protection in adult cardiac surgery. A significant decrease in postoperative stroke will require further research to shed light on the results of this study. VIDEO ABSTRACT.

Identifiants

pubmed: 35279289
pii: S0022-5223(22)00123-4
doi: 10.1016/j.jtcvs.2022.01.044
pii:
doi:

Substances chimiques

Cardioplegic Solutions 0
Troponin 0

Banques de données

ClinicalTrials.gov
['NCT04094168']

Types de publication

Randomized Controlled Trial Video-Audio Media Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1458-1467

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Jessica Garcia-Suarez (J)

Department of Anesthesiology and Critical Care, Puerta de Hierro University Hospital, Madrid, Spain. Electronic address: Jessicag.suarez@gmail.com.

Javier Garcia-Fernandez (J)

Department of Anesthesiology and Critical Care, Puerta de Hierro University Hospital, Madrid, Spain.

Daniel Martinez Lopez (D)

Department of Cardiac Surgery, Puerta de Hierro University Hospital, Madrid, Spain.

Leticia Reques (L)

Cardiac Surgery Perfusion Department, Puerta de Hierro University Hospital, Madrid, Spain.

Sergio Sanz (S)

Department of Anesthesiology and Critical Care, Puerta de Hierro University Hospital, Madrid, Spain.

Daniel Carballo (D)

Department of Anesthesiology and Critical Care, Puerta de Hierro University Hospital, Madrid, Spain.

Carlos Esteban Martin (CE)

Department of Cardiac Surgery, Puerta de Hierro University Hospital, Madrid, Spain.

Victor Manuel Ospina (VM)

Department of Cardiac Surgery, Puerta de Hierro University Hospital, Madrid, Spain.

Susana Villar (S)

Department of Cardiac Surgery, Puerta de Hierro University Hospital, Madrid, Spain.

Ana Martin (A)

Cardiac Surgery Perfusion Department, Puerta de Hierro University Hospital, Madrid, Spain.

Maria Casado (M)

Department of Anesthesiology and Critical Care, Puerta de Hierro University Hospital, Madrid, Spain.

Ana Villafranca (A)

Department of Anesthesiology and Critical Care, Puerta de Hierro University Hospital, Madrid, Spain.

Ana Isabel Gonzalez (AI)

Department of Anesthesiology and Critical Care, Puerta de Hierro University Hospital, Madrid, Spain.

Santiago Serrano (S)

Department of Cardiac Surgery, Puerta de Hierro University Hospital, Madrid, Spain.

Alberto Forteza (A)

Department of Cardiac Surgery, Puerta de Hierro University Hospital, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH